Skip to main content
Log in

Antidepressant drugs increase the locomotor hyperactivity induced by MK-801 in rats

  • Full Papers
  • Published:
Journal of Neural Transmission / General Section JNT Aims and scope Submit manuscript

Summary

MK-801, a non-competitive NMDA receptor antagonist, induced the locomotor hyperactivity in rats. Imipramine (IMI), amitriptyline (AMI), citalopram (CIT) given acutely increased the MK-801-induced locomotor hyperactivity. Mianserin (MIA) showed a similar but weaker effect. Haloperidol completely blocked the hyperactivity induced by the antidepressant drug (AD) + MK-801. Prazosin had an only weak antagonistic effect. Repeated treatment with AD increased the MK-801 locomotor hyperactivity to a greater extent than acute treatment. This effect was completely blocked by haloperidol and only partly by prazosin.

The obtained results indicate that the dopamine system may be involved, at least in part, in the potentiating effect of the combined treatment with AD + MK-801.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Arnt J, Hyttel J, Fredericson Overo K (1984) Prolonged treatment with the specific 5-HT- uptake inhibitor citalopram: effect of dopaminergic and serotonergic function. Pol J Pharmacol Pharm 36: 221–230

    Google Scholar 

  • Carlsson M, Carlsson A (1989a) Dramatic synergism between MK-801 and clonidine with respect to locomotor stimulatory effect in monoamine-depleted mice. J Neural Transm 77: 65–71

    Google Scholar 

  • Carlsson M, Carlsson A (1989b) The NMDA antagonist MK-801 causes marked locomotor stimulation in monoamine-depleted mice. J Neural Transm 75: 221–226

    Google Scholar 

  • Carlsson M, Svensson A (1990) Interfering with glutamatergic neurotransmission by means of NMDA antagonist administration discloses the locomotor stimulatory potential of other transmitter systems. Pharmacol Biochem Behav 36: 45–50

    Google Scholar 

  • Clineschmidt BV, Gregory EM, Bunting PR, Papp NL (1982) Central sympathomimetic activity of (+)-5-Methyl-10,11-dihydro-5 H-dibenzo(a,d)cyclohepten-5,10-imine (MK-801), a substance with potent anticonvulsant, central sympathomimetic and apparent anxiolytic properties. Drug Dev Res 2: 135–145

    Google Scholar 

  • De Montis GM, Devoto P, Gessa GL, Meloni D, Porcella A, Saba P, Serra G, Tagliamonte A (1989) Chronic imipramine reduces3H-SCH 23390 binding and dopamine sensitive adenylate cyclase in the limbic system. Eur J Pharmacol 167: 299–303

    Google Scholar 

  • De Montis GM, Devoto P, Gessa GL, Meloni D, Porcella A, Saba P, Serra G, Tagliamonte A (1990a) Central dopaminergic transmission is selectively increased in the limbic system of rats chronically exposed to antidepressants. Eur J Pharmacol 180: 31–35

    Google Scholar 

  • De Montis GM, Devoto P, Gessa GL, Porcella A, Serra G, Tagliamonte A (1990b) Possible roles of DA receptors in the mechanism of action of antidepressants. In: Gessa GL, Serra G (eds) Advances in the biosciences 77. Pergamon Press, Oxford New York, pp 147–157

    Google Scholar 

  • Dimpfel W, Spüler M (1990) Dizocilpine (MK-801), ketamine and phencyclidine: low doses affect brain field potentials in the frelly moving rat in the same way as activation of dopaminergic transmission. Psychopharmacology 101: 317–323

    Google Scholar 

  • Halaris A, Belendiuk K, Freedman DX (1975) Antidepressant drug affect dopamine uptake. Biochem Pharmacol 24: 1896–1898

    Google Scholar 

  • Hiramatsu M, Cho AK, Nabeshima T (1989) Comparison of the behavioral and biochemical effects of the NMDA receptor antagonists MK-801 and phencyclidine. Eur J Pharmacol 166: 359

    Google Scholar 

  • Kashihara K, Hamamura T, Okumura K, Otsuki S (1990) Effect of MK-801 on endogenous dopamine release in vivo. Brain Res 528: 80–82

    Google Scholar 

  • Klockgether T, Turski L, Loschmann P-A, Wachtel H (1990) N-Methyl-D-aspartate antagonists stimulate locomotor activity in monoamine depleted rats: implications for the therapy of Parkinson's disease. In: Lubec G, Rosenthal GA (eds) Amino acidschemistry, biology and medicine. Escom, Leiden, pp 276–280

    Google Scholar 

  • Koek W, Woods JH, Winger GD (1988) MK-801, a proposed noncompetitive antagonist of excitatory amino acid neurotransmission, produces phencyclidine-like behavioural effects in pigeons, rats and rhesus monkeys. J Pharmacol Exp Ther 245: 969–974

    Google Scholar 

  • Maj J (1984) Mechanism of action of antidepressant drugs given repeatedly: changes in the responses mediated by noradrenaline (α1) and dopamine receptors. In: Paton W, Michell J, Turner P (eds) Proceedings of the IUPHAR 9th International Congress of Pharmacology, London 1984. Macmillan Press, vol 3, pp 137–143

    Google Scholar 

  • Maj J (1986) Repeated treatment with antidepressant drugs: responses mediated by brain dopamine receptors. In: Hippius H, Klerman GL, Matussek N (eds) New results in depression research. Springer, Berlin Heidelberg New York, pp 90–98

    Google Scholar 

  • Maj J, Mogilnicka E, Klimek V (1977) Dopaminergic stimulation enhances the utilization of noradrenaline in the central nervous system. J Pharm Pharmacol 29: 569–570

    Google Scholar 

  • Maj J, Sowińska H, Baran L, Gancarczyk L, Rawlw A (1978) The central antiserotonergic action of mianserin. Psychopharmacology 59: 79–84

    Google Scholar 

  • Maj J, Rogóż Z, Skuza G, Sowińska H (1984) Repeated treatment with antidepressant drugs increase the behavioural response to apomorphine. J Neural Transm 60: 273–282

    Google Scholar 

  • Maj J, Rogóż Z, Skuza G, Sowinska H (1985) The effects of repeated treatment with antidepressant drugs on the action of D-amphetamine and apomorphine in rats. In: Keleman K, Magyar K, Vizi ES (eds) Neuropharmacology '85. Akademiai Kiado, Budapest, pp 133–139

    Google Scholar 

  • Maj J, Wedzony K, Skuza G (1986) Subsensitivity of presynaptic and supersensitivity of postsynaptic dopaminergic receptors as a result of repeated administration of antidepressant drugs. In: Knoll J, Keleman K (eds) Advances in pharmacological research and practice. Proc 4th Congress of the Hungarian Pharmacological Society, vol 2. Akademiai Kiado, Budapest, pp 47–55

    Google Scholar 

  • Maj J, Wedzony K, Klimek V (1987) Desipramine given repeatedly enhances behavioural effects of dopamine and d-amphetamine injected into the nucleus accumbens. Eur J Pharmacol 140: 179–185

    Google Scholar 

  • Maj J, Rogóz Z, Skuza G (1991) Locomotor hyperactivity induced by MK-801 in rats. Pol J Pharmacol Pharm (in press)

  • Martin GE (1986) Catecholamine release within the striatum of the freely moving rat. Ann NY Acad Sci 473: 151–159

    Google Scholar 

  • Martin-Iverson MT, Leclere JF, Fibiger HC (1983) Cholinergic interactions and the mechanism of action of antidepressants. Eur J Pharmacol 94: 193–201

    Google Scholar 

  • Mehta AK, Ticku MK (1990) Role of N-methyl-D-aspartate (NMDA) receptors in experimental catalepsy in rats. Life Sci 46: 37–42

    Google Scholar 

  • Meldrum BS (1985) Possible therapeutic applications of antagonists of excitatory amino acid neurotransmitters. Clin Sci 68: 113–122

    Google Scholar 

  • Morelli M, Di Chiara G (1990) MK-801 potentiates dopaminergic D1 but reduces D2 responses in the 6-hydroxydopamine model of Parkinson's disease. Eur J Pharmacol 182: 611–612

    Google Scholar 

  • Plaźnik A, Kostowski W (1987) The effects of antidepressants and electroconvulsive shock on the functioning of the mesolimbic dopaminergic system: a behavioural study. Eur J Pharmacol 135: 389–396

    Google Scholar 

  • Randrup A, Braestrup C (1977) Uptake inhibition of biogenic amines by newer antidepressant drugs: relevance to the dopamine hypothesis of depression. Psychopharmacology 53: 309–314

    Google Scholar 

  • Reynold IJ, Miller RJ (1988) Tricyclic antidepressants block N-methyl-D-aspartate receptors: similarities to the action of zinc. Br J Pharmacol 95: 95–102

    Google Scholar 

  • Schmidt WJ, Bubser M (1989) Anticataleptic effects of N-methyl-D-aspartate antagonist MK-801 in rats. Pharmacol Biochem Behav 32: 621–623

    Google Scholar 

  • Snell LD, Yi S-J, Johnson KM (1988) Comparison of the effect of MK-801 and phencyclidine on catecholamine uptake and NMDA-induced norepinephrine release. Eur J Pharmacol 145: 223–226

    Google Scholar 

  • Spyraki C, Fibiger HC (1981) Behavioural evidence for supersensitivity of postsynaptic dopamine receptors in the mesolimbic system after chronic administration of desipramine. Eur J Pharmacol 74: 195–206

    Google Scholar 

  • Tiedtke PJ, Bischoff C, Schmidt WJ (1990) MK-801-induced stereotypy and its antagonism by neuroleptic drugs. J Neural Transm [Gen Sect] 81: 173–182

    Google Scholar 

  • Trullas R, Skolnick P (1990) Functional antagonists at the NMDA receptor complex exhibit antidepressant actions. Eur J Pharmacol 185: 1–10

    Google Scholar 

  • Wong EHF, Kemp JA, Priestley T, Knight AR, Woodruff GN, Iversen LL (1986) The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist. Proc Natl Acad Sci USA 83: 7104–7108

    Google Scholar 

  • Wong EHF, Knigh AR, Woodruff GN (1988) [3H] MK-801 labels a site on the N-methyl-D-aspartate receptor channel complex in rat brain membranes. J Neurochem 50: 274–281

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Maj, J., Rogóż, Z. & Skuza, G. Antidepressant drugs increase the locomotor hyperactivity induced by MK-801 in rats. J. Neural Transmission 85, 169–179 (1991). https://doi.org/10.1007/BF01244943

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01244943

Keywords

Navigation